News & Analysis on Clinical Trial Services & Contract Research And Development
ExonHit and bioMirieux have announced that scientific data generated in the detection of breast cancer could well lead to the development of novel diagnostic tests that will enable the early detection of breast cancer from blood.
Despite the technological breakthroughs that have enhanced the R&D capabilities of pharmaceutical companies, drug research and development is facing a major problem as R&D productivity in the last decade is at a historical low despite recent innovations.
Nypro, a large US-based provider of precision plastics injection moulding, has been contracted to manufacture Ventaira's new pulmonary drug delivery device.
Scientists have discovered the existence of a HIV accessory protein that disables host immunity via receptor-protein intermediary in a discovery that points to possible novel ways to fight AIDS, immune disorders and sepsis.
As pharma companies tighten their belts, they are expecting more and more cost savings from their outsourcing providers. IT services company HCL Technologies spoke to Outsourcing-Pharma.com at Interphex in New York to explain how it is providing major...
No company likes to hire and fire unnecessarily. When used correctly, outsourcing can be the key to maintaining the proper balance of fixed and variable staffing and allow the right staffing resources to be rapidly shifted to the right place at the...
Agilent has upgraded its GeneSpring GX 7.3 gene expression informatics software, giving it new features designed to allow researchers to understand faster what their results really mean.
Upstate and Cisbio have announced the launch of an assay for Serine/Threonine kinase screening that offers simplified kinase assay development, which allows for profiling and high-throughput screening (HTS) on a large range of Ser/Thr kinases, major...